Overview
News
Technologies
Salaries
Products
People
Growth
Financials

Overview

RAPS is proud to serve as the largest and most trusted global organization dedicated to supporting and advancing the regulatory profession and enhancing the development and careers of regulatory and quality professionals worldwide.

News

News raps.org 11 days ago
FDA finalizes Q&A guidance on developing cell and gene therapies
The US Food and Drug Administration (FDA) on Wednesday finalized guidance addressing frequently asked questions related to the development of cellular and gene therapy (CGT) products.
Read more
Report
News raps.org 11 days ago
Experts discusses need to modernize evidentiary models in rare diseases
Using the US Food and Drug Administration's (FDA) plausible mechanism framework to allow for greater use of causal inference may help with evidence generation for rare diseases, according to a recent paper published in The Journal of Clinical Investigatio
Read more
Report
News raps.org 11 days ago
Euro Roundup: EMA seeks feedback on framework designed to drive uptake of data standards
The European Medicines Agency (EMA) is holding a consultation about a draft framework intended to cut the time it takes to implement data standards.
Read more
Report
News raps.org 11 days ago
Recon: FDA approves Ultragenyx gene therapy for glycogen storage disorder; Overton faces confirmation challenges
Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.
Read more
Report
News raps.org 13 days ago
Study highlights limits of premarket evaluation for identifying recalls of high-risk medical devices
More than one-third of high-risk therapeutic medical devices approved over the last decade were subject to serious recalls, but the lack of consistent characteristics of these recalled devices suggests the need for greater postmarket surveillance, accordi
Read more
Report
Pro access
Upgrade to see all 38 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.